1. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies

   • Patricia Horan Hand
   • Paul F. Robbins
   • Jeffrey Schlom

   Original articles Pages: 65 - 75

2. Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro

   • Toshiyuki Takahashi
   • Hiroshi Ishikura
   • Takashi Yoshiki

   Original articles Pages: 76 - 82

3. Recognition of the Qa-2^k tumor antigen by T cell receptor γ/δ of an immunopotentiator-induced tumoricidal T cell of mice

   • Takahiro Okazaki
   • Chiemi Nakanishi-Ito
   • Kohji Egawa

   Original articles Pages: 83 - 88

4. Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells

   • G. Hedlund
   • M. Dohlsten
   • T. Kalland

   Original articles Pages: 89 - 93

5. Characterization of a monoclonal antibody reactive with a glycolipid antigen expressed by tumorigenic and certain immortalized, non-tumorigenic rat esophageal epithelial cell lines

   • Xingsheng Wan
   • Roudabeh J. Jamasbi
   • Gary D. Stoner

   Original articles Pages: 94 - 100

6. Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells

   • Avi Eisenthal
   • Hanoch Kashtan
   • Yehuda Skornick

   Original articles Pages: 101 - 107

7. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormones

   • Maarten P. R. Tas
   • Peter J. Simons
   • Hemmo A. Drexhage

   Original articles Pages: 108 - 114

8. The influence of cyclophosphamide on antitumor immunity in mice bearing late-stage tumors

   • Filip Čulo
   • Ivica Klapan
   • Toni Kolak

   Original articles Pages: 115 - 122

9. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells

   • Andrea Ladányi
   • József Tímár
   • Károly Lapis

   Original articles Pages: 123 - 126

10. Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapy

    • Marek Zembala
    • Antoni Czupryna
    • Tadeusz Popiela

    Original articles Pages: 127 - 132

11. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

    • Anita S. -F. Chong
    • Penelope N. Markham
    • John S. Coon

    Short communication Pages: 133 - 139

12. Acknowledgement to reviewers

    Acknowledgments Pages: 140 - 140